| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 62.14× | 62.14× | 55.81× | 63.31× | 93.65× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.64× | — | — | — | — | ||
| 0.32× | 0.32× | 0.37× | 0.37× | 0.32× | ||
| 2.83× | 2.83× | 0.97× | −0.83× | 0.37× | ||
| 1.47× | 1.47× | 0.59× | −0.54× | 0.26× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 93.65 | 63.31 | 55.81 | 62.14 | 62.14 | |
| Working Capital Turnover | — | — | — | — | 0.64 | |
| Asset Turnover | 0.32 | 0.37 | 0.37 | 0.32 | 0.32 | |
| Cash Conversion (CFO/Net Income) | 0.37 | -0.83 | 0.97 | 2.83 | 2.83 | |
| CFO/EBITDA | 0.26 | -0.54 | 0.59 | 1.47 | 1.47 |